Related Experiment Video
Updated: Jun 26, 2026

Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
Current and emerging treatments for mild/moderate acute ambulatory pain
1Section of Rheumatology and Immunology, University of Nebraska Medical Center, Omaha, NE, USA. weaver2aj@tds.net
Abstract:
Nonsteroidal anti-inflammatory drugs (NSAIDs), the mainstay of therapy for acute musculoskeletal pain, are among the most widely used drugs in the world. The major limitation of traditional (nonselective) NSAIDs is gastrointestinal (GI) toxicity, which includes dyspepsia, mucosal injury, and serious events, such as ulcers, GI bleeding, and perforation. This article reviews the mechanism of action, safety, and efficacy of traditional and selective NSAIDs (coxibs); risk factors for GI complications; and strategies for reducing risk and preventing NSAID-related gastropathy and cardiovascular complications. The article also discusses the use of aspirin for cardioprotection in patients taking analgesic/anti-inflammatory agents for musculoskeletal pain and the need to balance competing GI and cardiovascular risks. Topical NSAIDs and other formulations that may prove to be safer than currently available agents also are addressed.
Related Concept Videos
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Peripheral Artery Disease V: Postoperative Nursing Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Peripheral Artery Disease III: Interprofessional Care
Drug Therapy
Antianxiety Medications
